Today let’s take a look at the cannabichromene (CBC), a non-psychoactive cannabinoid with various benefits. CBC does not bind well to CB1 receptors throughout the brain, but it is able to bind with other receptors like the TRPV1 receptor and the TRPA1 receptor, both of which a receptors that play a role in pain perception. When CBC interacts with these receptors, it increases the production of some of the body’s natural endocannabinoids like anandamide.
CBC is a powerful cannabinoids on its own and in conjunction with other cannabinoids. CBC may be the second most powerful cannabinoid to inhibit the growth of new cancer cells, and it inhibits the uptake of the endocannabinoid anandamide, which has been shown to fight breast cancer in vitro and in vivo. CBC has also been found to block pain and inflammation associated with collagen-induced osteoarthritis, and in one animal study, it produced an even greater anti-inflammatory effect alongside THC than the two could produce on their own. CBC may also benefit brain function, and one 2013 study involving mice found the cannabinoid made neural step progenitor cells (NSPCs) more viable. The cannabinoid is also a powerful inhibitor of acne through its anti-inflammatory properties and its ability to suppress excessive lipid production in sebaceous glands. CBC may also produce antidepressant properties when working synergistically alongside THC and CBD.
This information has been brought to you by Leafly and approved by our Chief Medical Officer.